LDL Can Help Promote Cancer Metastasis
Researchers have identified that other than clogging the arteries, LDL can also promote metastatic cancer cells, which break away from the parent tumor, to reattach at distant site.
Castellani: Health Law's Cost-Sharing Could Limit Patient Access To Prescription Drugs
Enrollees in some of the health law's most popular plans will face high cost-sharing requirements that the pharmaceutical industry says could keep patients from getting the drugs they need.
Arizona Offers 'Sneak Peak' At Costs Of Shifting Kids Off CHIP
Families of Arizona children who were forced to switch from the Children's Health Insurance Program (CHIP) to private plans sold in the federal marketplace are likely paying more and getting fewer benefits, according to a study by Georgetown University researchers released Thursday.
Phone App For Melanoma Screening to be Tested at MD Anderson
DermoScan, created by an engineering faculty at the University of Houston, can help screen for melanoma. It has already been used to diagnose a dermal bacterial disease in Africa, in a NIH-sponsored study.
Limited Medicare ACO Quality Data Show Sharp Variations in Performance
Since the Obama administration launched its accountable care initiative as part of healthcare reform in 2012, the CMS has announced which hospital and physician networks in one of the programs have met cost targets and received shared savings. But so far, it has published little data on quality of care delivered by these networks, which were designed to deliver better care as well as lower costs for Medicare patients.
HHS Claims Big Gains on Readmissions, Hospital-Acquired Harms
The Obama administration says the number of Medicare patients returning to hospitals within 30 days fell further in 2013, amounting to 150,000 fewer readmissions since January 2012.
Myriad and UHC Sign a 3-year Contract for the myRisk Hereditary Cancer Test
The molecular diagnostic testing company Myriad Genetics announced that it had signed a 3-year contract with UnitedHealthcare to make their myRisk cancer susceptibility test accessible to patients.
Merck's PD-1 Antibody for Metastatic Melanoma to Get Priority Review
Merck announced that the FDA has granted a priority review for it's anti-PD-1 antibody, MK-3475, under the accelerated approval program, for the treatment of metastatic melanoma.
Patrick Kennedy Talks Mental Health Parity With AJMC
The former Congressman discussed his goal of finding common ground on what constitutes mental health while at the 167th Annual Meeting of the American Psychiatric Association.
New Biomarker Identified for Esophageal Cancer
A new biomarker for esophageal cancer shows promise in improving screening for this deadly disease and its precursor, Barrett's esophagus.
Hospital Medicine's Role in Healthcare System Under Affordable Care Act Takes Shape
Hospitalists to field changes in patient care delivery, health policies propelled by Obamacare for decades.
Bone Marrow-On-A-Chip: New Method to Evaluate Toxicity
Bioengineers at Harvard have devised a chip with bone marrow to test chemotherapy and radiation-associated toxicity, bypassing the need to use animal models.
Cryoablation of Early Breast Cancer Tumors
Cryotherapy, already being used for benign breast tumors and several other cancers, might prove effective in women with breast cancer tumors 1 cm or smaller in size.
Why Sovaldi Shouldn't Cost $84,000
Medicaid managed-care plans are demanding relief from state officials to meet mounting outlays for Gilead Sciences' wonder drug, while insurer WellPoint called Sovaldi its biggest watch item.
Phase 3 PROCEED Trial of Vintafolide Halted
Vintafolide, jointly being developed by Merck and Endocyte, failed to present efficacy on PFS in Phase 3 trials, resulting in early termination.
Flatiron's OncologyCloud Could be Big News
OncologyCloud, a platform developed by Flatiron Health, is already in partnership with more than 25 cancer centers to help address some of the bottlenecks in cancer care.
How PCORI Can Improve Quality Of Care (And Prove It) By 2019
Despite the considerable resources designated to PCORI, its future remains tenuous.
Report: Healthcare Access, Affordability Declined From 2007 to 2012
States did little to improve healthcare access, quality, costs and outcomes in the past five years, according to a Commonwealth Fund report. Researchers examined 42 health indicators between 2007 and 2012, and found that in many states, access and affordability of healthcare actually declined among adults younger than 65. Healthcare spending rose $491 billion, reaching $2.8 trillion nationally.
High Dose of Opioids Post-surgery Tied to NSCLC Recurrence
Non-small cell lung cancer (NSCLC) patients who experienced disease recurrence half a decade after surgery received a significantly higher dose of opioids postoperatively, researchers said here.
Medicare Proposes Higher Hospice Payments
The CMS intends increase Medicare payments to hospices and also make several tweaks to policy definitions and procedures to ensure more accurate reimbursement.
Demcizumab by OncoMed Receives Orphan Drug Status for Pancreatic Cancer
Demcizumab, a monoclonal antibody that targets the Notch signaling pathway, has been awarded an orphan drug status by the FDA in the treatment of pancreatic cancer.
Doctors Think Others Often Prescribe Unnecessary Care
Three out of four physicians believe that fellow doctors prescribe an unnecessary test or procedure at least once a week, a survey released Thursday finds.
Newly Approved Telehealth Guideline Causes a Stir
The Federation of State Medical Boards approved a model telehealth policy this weekend that's made some providers of these services happy and others, well, not so much, because of its emphasis on using video rather than audio technology for a first patient visit.
Hyperfractionated Radiation Therapy: Improved Local-Regional Control and OS in HNSCC
Patients with locally advanced squamous cell carcinoma of the head and neck treated with hyperfractionated radiation therapy (HFX) experienced improved local-regional control and, with patients censored at five years, improved overall survival with no increase in late toxicity.